Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...

In a report released today, James Rose from Barclays maintained a Buy rating on Experian (EXPGF – Research Report), with a price target of ...

Barclays shares have carried on where they left off in 2024, by climbing far faster than the FTSE 100. Harvey Jones wonders ...

Barclays also has credit cards and personal loans. Barclays is a global investment bank and financial services corporation. It provides a variety of banking and wealth management services to ...

Genasys Price Performance NASDAQ:GNSS opened at $3.01 on Friday. Genasys Inc. has a 52 week low of $1.51 and a 52 week high of $4.04. The company has a debt-to-equity ratio of 0.68, a quick ratio ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. With no minimum deposit requirements and high interest rates, Barclays is a ...

Barclays US, the online bank subsidiary ... That’s good because you won’t find checking or investment options. Available to new to bank customers (existing Savings and CD accounts holders ...

Commissions do not affect our editors' opinions or evaluations. Barclay Bank offers nine high-yield certificates of deposit (CDs), ranging from three months to 60 months. The bank’s CD rates are ...

Goldman Sachs announced a leadership reshuffle this week that created a new layer of management for its all-important investment bank. As part of the reshuffle, Goldman tapped three of its most ...

I feel very happy with the investment bank.” The comments come about a year after Venkatakrishnan unveiled a new strategy for Barclays. The size of Barclays’ investment bank has long been a ...

That should be good news for Barclays’ investment bankers and traders, Chief Executive Officer C.S. Venkatakrishnan told Francine Lacqua in a Bloomberg Television interview on Wednesday.